Sotera Health Company

SHC Healthcare Diagnostics & Research

Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024. In the quarter to June 2026, revenue grew 9.18%, EPS grew 533.3%, free cash flow grew 60.6% and total debt fell 3.54%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

17.89 0.18 −1.00%
Market cap
$5.2B
P/E
31.4×
Fwd P/E
23.7×
Dividend yield
—
F-score
7/9
Altman Z
1.76
Beneish M
−2.75
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
31.14 34.98 65.33 82.79

+8 more quarters

P/S ratio
4.17 3.44 4.30 3.88
P/FCF ratio
45.01 42.18 33.58 51.59
P/Operating CF
57.32 138.79 48.58 62.80
P/B ratio
7.62 6.56 8.27 8.12
EV/Sales
5.71 5.05 5.93 5.57
EV/EBITDA
13.10 11.69 13.68 12.98
EV/FCF
61.64 61.96 46.23 73.94
Current Ratio
2.80 2.82 2.46 2.38
Net Debt/EBITDA
13.22 17.72 13.55 13.75
Debt/Equity
3.35 3.58 3.69 4.06
Earnings Yield
3.21% 2.86% 1.53% 1.21%
Free Cash Flow Yield
2.22% 2.37% 2.98% 1.94%
Free Cash Flow per Share
0.15 (0.06) 0.18 0.12
Book value per Share
2.33 2.19 2.13 1.94
Free Cash Flow
42.05 (16.73) 52.41 34.98
EV/EBIT
17.40 15.76 19.05 18.63
Other line items

Show all line items

Columns are period end dates